These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3754787

  • 1. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
    Odaimi M, Andersson BS, McCredie KB, Beran M.
    Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
    [Abstract] [Full Text] [Related]

  • 2. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
    Beran M, Andersson BS.
    Cancer Res; 1987 Apr 01; 47(7):1897-904. PubMed ID: 3469023
    [Abstract] [Full Text] [Related]

  • 3. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
    Wilson WR, Giesbrecht JL, Hill RP, Whitmore GF.
    Cancer Res; 1981 Jul 01; 41(7):2809-16. PubMed ID: 6894713
    [Abstract] [Full Text] [Related]

  • 4. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
    Bakic M, Chan D, Andersson BS, Beran M, Silberman L, Estey E, Ricketts L, Zwelling LA.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4067-77. PubMed ID: 2825713
    [Abstract] [Full Text] [Related]

  • 5. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 6. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression.
    Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM.
    Cancer Res; 1989 Aug 15; 49(16):4542-9. PubMed ID: 2568172
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [Abstract] [Full Text] [Related]

  • 8. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
    Wilson WR, Whitmore GF, Hill RP.
    Cancer Res; 1981 Jul 15; 41(7):2817-22. PubMed ID: 7018670
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA, Kerrigan D, Michaels S.
    Cancer Res; 1982 Jul 15; 42(7):2687-91. PubMed ID: 6896293
    [Abstract] [Full Text] [Related]

  • 10. The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.
    Estey EH, Silberman L, Beran M, Andersson BS, Zwelling LA.
    Biochem Biophys Res Commun; 1987 Apr 29; 144(2):787-93. PubMed ID: 3034264
    [Abstract] [Full Text] [Related]

  • 11. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
    Del Bino G, Darzynkiewicz Z.
    Cancer Res; 1991 Feb 15; 51(4):1165-9. PubMed ID: 1997159
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
    Robbie MA, Baguley BC, Denny WA, Gavin JB, Wilson WR.
    Cancer Res; 1988 Jan 15; 48(2):310-9. PubMed ID: 2825971
    [Abstract] [Full Text] [Related]

  • 16. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer.
    Legha SS, Blumenschein GR, Buzdar AU, Hortobagyi GN, Bodey GP.
    Cancer Treat Rep; 1979 Jan 15; 63(11-12):1961-4. PubMed ID: 526929
    [Abstract] [Full Text] [Related]

  • 17. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
    Pommier Y, Schwartz RE, Zwelling LA, Kerrigan D, Mattern MR, Charcosset JY, Jacquemin-Sablon A, Kohn KW.
    Cancer Res; 1986 Feb 15; 46(2):611-6. PubMed ID: 3000581
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.